Clobazam — 2.5MG/ML, Suspension, carton of 1 × 120 mL bottle

Clobazam — 2.5MG/ML, Suspension, carton of 1 × 120 mL bottle

Clobazam is a suspension for oral use. Clobazam oral suspension is indicated for the adjunctive treatment of seizures associated with Lennox-Gastaut syndrome (LGS) in patients 2 years of age or older. Clobazam oral suspension is a benzodiazepine indicated for adjunctive treatment of seizures associated with Lennox-Gastaut syndrome (LGS) in patients 2 years of age or older ( 1 )

• Active ingredient or product type: CLOBAZAM
• Strength/concentration: 2.5MG/ML
• Dosage form and route: Suspension, Oral
• Exact package presentation: carton of 1 × 120 mL bottle
• NDC/item number: 67877-658-61
• Manufacturer: ASCEND LABORATORIES LLC
• Storage/handling: Store and dispense clobazam oral suspension in its original bottle in an upright position. discard any remainder. Store oral suspension at 20°C to 25°C (68°F to 77°F). [See USP Controlled Room Temperature].
• Status: Rx only

Important safety information: Somnolence or Sedation: Monitor for central nervous system (CNS) depression.

Refer to the current product labeling for complete indications, preparation or administration instructions, contraindications, warnings, precautions, and storage requirements.